Fabrice Balavoine

2.0k total citations · 1 hit paper
29 papers, 1.7k citations indexed

About

Fabrice Balavoine is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Fabrice Balavoine has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 11 papers in Molecular Biology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Fabrice Balavoine's work include Renin-Angiotensin System Studies (12 papers), Neuropeptides and Animal Physiology (8 papers) and Hormonal Regulation and Hypertension (7 papers). Fabrice Balavoine is often cited by papers focused on Renin-Angiotensin System Studies (12 papers), Neuropeptides and Animal Physiology (8 papers) and Hormonal Regulation and Hypertension (7 papers). Fabrice Balavoine collaborates with scholars based in France, United States and Belgium. Fabrice Balavoine's co-authors include Charles Mioskowski, Patrick Schultz, Cyrille Richard, Thomas W. Ebbesen, Véronique Mallouh, Catherine Llorens‐Cortés, Yannick Marc, Bernárd P. Roques, Michel Azizi and Nicolas Inguimbert and has published in prestigious journals such as Science, Angewandte Chemie International Edition and Circulation.

In The Last Decade

Fabrice Balavoine

27 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Supramolecular Self-Assembly of Lipid Derivatives on Carbon Nanotubes

2003 656 citations Cyrille Richard, Fabrice Balavoine et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fabrice Balavoine France	17	761	471	384	366	279	29	1.7k
L. Fröhlich Germany	17	303 0.4×	578 1.2×	233 0.6×	113 0.3×	242 0.9×	26	1.5k
Tomotsumi Fujisawa Japan	22	287 0.4×	324 0.7×	466 1.2×	34 0.1×	67 0.2×	65	1.8k
M. Steiner Germany	20	262 0.3×	308 0.7×	512 1.3×	41 0.1×	373 1.3×	47	1.5k
Pedro F. Aramendı́a Argentina	26	962 1.3×	263 0.6×	411 1.1×	208 0.6×	146 0.5×	104	2.0k
Thomas J. Cahill United States	15	190 0.2×	290 0.6×	587 1.5×	44 0.1×	78 0.3×	29	1.5k
Peter Kohn Germany	20	366 0.5×	138 0.3×	310 0.8×	35 0.1×	701 2.5×	33	1.5k
Y. Sasaki Japan	18	224 0.3×	49 0.1×	140 0.4×	123 0.3×	143 0.5×	34	1.3k
Lijun Geng China	22	617 0.8×	90 0.2×	247 0.6×	42 0.1×	48 0.2×	93	1.4k
Craig A. Aspinwall United States	23	161 0.2×	442 0.9×	828 2.2×	19 0.1×	216 0.8×	66	1.7k
Rafael Piñol Spain	22	499 0.7×	302 0.6×	167 0.4×	163 0.4×	124 0.4×	41	1.3k

Countries citing papers authored by Fabrice Balavoine

Since Specialization

Citations

This map shows the geographic impact of Fabrice Balavoine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Balavoine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Balavoine more than expected).

Fields of papers citing papers by Fabrice Balavoine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrice Balavoine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Balavoine. The network helps show where Fabrice Balavoine may publish in the future.

Co-authorship network of co-authors of Fabrice Balavoine

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Balavoine. A scholar is included among the top collaborators of Fabrice Balavoine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Balavoine. Fabrice Balavoine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Balavoine, Fabrice, Frédéric Miege, Nadia De Mota, et al.. (2024). Rational design, synthesis and pharmacological characterization of novel aminopeptidase A inhibitors. Bioorganic & Medicinal Chemistry Letters. 113. 129940–129940. 1 indexed citations

Montalescot, Gilles, John H. Alexander, Ángel Cequier, et al.. (2023). Firibastat Versus Ramipril After Acute Mechanical Reperfusion of Anterior Myocardial Infarction: A Phase 2 Study. American Journal of Cardiovascular Drugs. 23(2). 207–217. 6 indexed citations

Keck, Mathilde, Robin Deloux, Yannick Marc, et al.. (2022). QGC606: A Best-in-Class Orally Active Centrally Acting Aminopeptidase A Inhibitor Prodrug for Treating Heart Failure Following Myocardial Infarction. Canadian Journal of Cardiology. 38(6). 815–827. 6 indexed citations

Marc, Yannick, et al.. (2021). Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats. Biomedicine & Pharmacotherapy. 140. 111682–111682. 3 indexed citations

Marc, Yannick, Solène Emmanuelle Boitard, Fabrice Balavoine, Michel Azizi, & Catherine Llorens‐Cortés. (2020). Targeting Brain Aminopeptidase A: A New Strategy for the Treatment of Hypertension and Heart Failure. Canadian Journal of Cardiology. 36(5). 721–731. 26 indexed citations

Ferdinand, Keith C., Fabrice Balavoine, B. Besse, et al.. (2019). Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins. Circulation. 140(2). 138–146. 63 indexed citations

Azizi, Michel, Pierre‐Yves Courand, Thierry Denolle, et al.. (2019). A pilot double-blind randomized placebo-controlled crossover pharmacodynamic study of the centrally active aminopeptidase A inhibitor, firibastat, in hypertension. Journal of Hypertension. 37(8). 1722–1728. 35 indexed citations

Keck, Mathilde, Nicolas Inguimbert, Adrien Flahault, et al.. (2019). NI956/QGC006, a Potent Orally Active, Brain-Penetrating Aminopeptidase A Inhibitor for Treating Hypertension. Hypertension. 73(6). 1300–1307. 22 indexed citations

Llorens‐Cortés, Catherine, Yannick Marc, Mathilde Keck, et al.. (2019). P4554Central-acting aminopeptidase a inhibitors for new treatment of hypertension: from discovery to clinical trial. European Heart Journal. 40(Supplement_1).

10.

Boitard, Solène Emmanuelle, Yannick Marc, Mathilde Keck, et al.. (2018). Brain renin-angiotensin system blockade with orally active aminopeptidase A inhibitor prevents cardiac dysfunction after myocardial infarction in mice. Journal of Molecular and Cellular Cardiology. 127. 215–222. 25 indexed citations

11.

Marc, Yannick, et al.. (2017). Central antihypertensive effects of chronic treatment with RB150. Journal of Hypertension. 36(3). 641–650. 33 indexed citations

12.

Balavoine, Fabrice, Michel Azizi, Damien Bergerot, et al.. (2013). Randomised, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Study of QGC001, a Centrally Acting Aminopeptidase A Inhibitor Prodrug. Clinical Pharmacokinetics. 53(4). 385–395. 44 indexed citations

13.

Marc, Yannick, et al.. (2012). Central Antihypertensive Effects of Orally Active Aminopeptidase A Inhibitors in Spontaneously Hypertensive Rats. Hypertension. 60(2). 411–418. 61 indexed citations

14.

Balavoine, Fabrice, et al.. (2007). Design and synthesis of novel hydantoin-containing melanin-concentrating hormone receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 17(13). 3754–3759. 11 indexed citations

15.

Richard, Cyrille, Fabrice Balavoine, Patrick Schultz, Thomas W. Ebbesen, & Charles Mioskowski. (2003). Supramolecular Self-Assembly of Lipid Derivatives on Carbon Nanotubes. Science. 300(5620). 775–778. 656 indexed citations breakdown →

16.

Lenne, Pierre‐François, B. Berge, Anne Renault, et al.. (2000). Synchrotron Radiation Diffraction from Two-Dimensional Protein Crystals at the Air/Water Interface. Biophysical Journal. 79(1). 496–500. 28 indexed citations

17.

Balavoine, Fabrice, Patrick Schultz, Cyrille Richard, et al.. (1999). Helicale Kristallisation von Proteinen auf Kohlenstoffnanoröhren: ein erster Schritt zur Entwicklung neuer Biosensoren. Angewandte Chemie. 111(13/14). 2036–2039. 1 indexed citations

18.

Balavoine, Fabrice, Patrick Schultz, Cyrille Richard, et al.. (1999). Helical Crystallization of Proteins on Carbon Nanotubes: A First Step towards the Development of New Biosensors. Angewandte Chemie International Edition. 38(13-14). 1912–1915. 369 indexed citations

19.

Bischler, Nicolas, Fabrice Balavoine, Philipp Milkereit, et al.. (1998). Specific Interaction and Two-Dimensional Crystallization of Histidine Tagged Yeast RNA Polymerase I on Nickel-Chelating Lipids. Biophysical Journal. 74(3). 1522–1532. 40 indexed citations

20.

Vénien‐Bryan, Catherine, Fabrice Balavoine, Bertrand Toussaint, et al.. (1997). Structural study of the response regulator HupR from Rhodobacter capsulatus. electron microscopy of two-dimensional crystals on a nickel-chelating lipid. Journal of Molecular Biology. 274(5). 687–692. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact